Remote ischemic conditioning in ST-segment elevation myocardial infarction - an update

Area of Science:

• Cardiovascular Medicine
• Regenerative Medicine
• Ischemia-Reperfusion Injury

Background:

• Acute myocardial infarction (AMI) and resulting heart failure (HF) are leading global causes of mortality and morbidity.
• Novel cardioprotective strategies are crucial to mitigate myocardial infarct (MI) size and prevent HF following acute ischemia/reperfusion injury (IRI).

Purpose of the Study:

• To evaluate the efficacy of remote ischemic conditioning (RIC) as a cardioprotective strategy against myocardial damage.
• To assess the potential of RIC in reducing MI size and preventing heart failure in patients with ST-segment elevation myocardial infarction (STEMI).

Main Methods:

• RIC involves inducing brief cycles of ischemia and reperfusion in a remote organ (e.g., arm or thigh) via cuff inflation/deflation.
• Experimental studies in animal models demonstrated RIC's ability to reduce MI size in acute IRI.
• Clinical studies investigated RIC in STEMI patients undergoing primary percutaneous coronary intervention (PPCI).

Main Results:

• Experimental studies consistently show that RIC reduces MI size in animal models of acute IRI.
• Clinical application of RIC in STEMI patients undergoing PPCI has demonstrated a reduction in MI size.
• The CONDI2/ERIC-PPCI trial is ongoing to definitively ascertain the clinical benefits of RIC.

Conclusions:

• Remote ischemic conditioning (RIC) is a promising, non-invasive strategy for cardioprotection.
• RIC has demonstrated efficacy in reducing myocardial infarct size in both experimental and clinical settings.
• Further clinical trials are essential to confirm the long-term benefits of RIC on clinical outcomes in STEMI patients.